![]() |
市场调查报告书
商品编码
1871886
全球高度个人化营养补充品市场:未来预测(至2032年)-依产品类型、个人化方法、剂型、通路、用途、最终用户和地区进行分析Hyper Personalized Supplementation Market Forecasts to 2032 - Global Analysis By Product Type, Personalization Approach, Dosage Form, Distribution Channel, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,全球高度个人化补充剂市场预计到 2025 年价值 13 亿美元,到 2032 年达到 23 亿美元,在预测期内以 8.5% 的复合年增长率增长。
高度个人化营养补充品是指根据个人独特的生物学特征、生活方式和健康数据精确配製的营养或膳食补充剂。这种方法整合了基因标记、微生物组谱、活动量和临床病史,以优化营养摄取和治疗效果。与千篇一律的解决方案不同,它强调数据驱动的个人化定制,旨在解决特定的营养缺乏、目标或疾病。这种调查方法支持积极主动的健康管理,提高疗效,并符合营养、预防医学和运动表现优化领域的个人化医疗趋势。
DTC平台的成长
数位化优先的健康平台正在改变消费者获取个人化营养补充剂的方式。这些平台根据基因、生活方式和生物特征数据提供量身定制的营养方案,无需传统的临床就诊。更友善的用户介面和人工智慧驱动的建议引擎使个人化营养方案更易于取得和推广。随着消费者越来越希望自主掌控自己的健康决策,直接面向消费者的模式正日益受到青睐。
缺乏针对个人化处方的标准化指南
原料来源、剂量客製化和测试通讯协定的差异会导致产品功效不一致。不同地区监管政策的不确定性进一步加剧了新参与企业市场进入的困难。由于缺乏统一的框架,製造商难以检验产品声明,也难以确保不同消费族群对产品的安全性。这种缺乏标准化的现状会削弱消费者的信任,并降低某些特定族群的产品接受度。
与生物技术和营养基因组学公司合作
与生物技术和营养基因组学公司的策略联盟正在为高度个人化开闢新的可能性。这些合作使得基因组分析、微生物组分析和代谢谱分析能够整合到膳食补充剂的设计中。利用先进的生物学数据,企业可以创建针对个人健康指标量身定制的精准配方。此类合作也有助于临床检验和监管合规,进而提升产品的可信度。
来自非专利药保健品品牌的竞争压力
由于价格实惠且供应广泛,非专利药生产商持续占据商店空间。其大众市场吸引力和成熟的分销网络对小众个人化产品构成威胁。认知有限或预算紧张的消费者可能会选择传统产品而非客製化产品。此外,非专利药激进的定价策略和促销宣传活动也可能削弱消费者对高度个人化解决方案的认知价值。
疫情加速了人们对免疫健康和个人化健康管理的关注,推动了高度个人化营养补充剂的短期成长。然而,供应链中断和临床试验能力下降暂时减缓了产品研发。在消费者方面,健康意识的提高和远距离诊断的普及推动了对客製化解决方案的需求。向远端医疗和数位营养平台的转变催生了新的通路和互动模式。
预计在预测期内,植物和草药萃取物细分市场将占据最大的市场份额。
由于植物和草药萃取物具有天然来源和广泛的治疗应用,预计在预测期内,其市场份额将占据最大。这些成分因其适应原、抗发炎和抗氧化特性而备受推崇,有助于实现个人化的健康目标。提取技术的进步和可追溯性系统的建立提高了产品品质和消费者信心。此外,文化上的亲和性以及对植物来源解决方案日益增长的偏好,正在推动各个年龄层的需求。
预计在预测期内,基于微生物组的个人化治疗细分市场将实现最高的复合年增长率。
在肠道健康研究和定序技术的突破性进展的推动下,基于微生物组的个人化客製化领域预计将在预测期内实现最高成长率。根据个人肠道微生物组特征量身定制的补充剂能够针对性地改善消化功能、免疫力和心理健康。粪便检验试剂盒与人工智慧驱动的微生物组分析相结合,使个人化定制更加精准且更具规模化。随着人们对肠-脑轴的科学认识不断加深,消费者对微生物组调节的兴趣也日益浓厚。
预计北美将在预测期内占据最大的市场份额,这得益于其强大的数位健康生态系统和较高的消费者健康意识。该地区先进的医疗保健基础设施和穿戴式装置的广泛应用,使得个人化处方的数据收集更加便捷且有效率。监管部门对营养补充品创新的支持以及电子商务市场的强劲渗透,进一步推动了市场成长。美国和加拿大的主要企业正在投资人工智慧、基因组学和直销模式,巩固其区域优势。
在预测期内,北美预计将实现最高的复合年增长率,这主要得益于可支配收入的增长、都市化的加快以及人们对个性化健康管理日益增长的兴趣。中国、印度和韩国等国家正在快速普及数位健康工具和基因检测服务。政府推行的预防性医疗保健和国内製造业发展倡议,为市场扩张创造了有利条件。当地文化对草药和均衡饮食的重视,也与个人化保健品的概念相契合。
According to Stratistics MRC, the Global Hyper Personalized Supplementation Market is accounted for $1.3 billion in 2025 and is expected to reach $2.3 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Hyper personalized supplementation is the precision-based formulation of dietary or wellness supplements tailored to an individual's unique biological, lifestyle, and health data. This approach integrates genetic markers, microbiome profiles, activity levels, and clinical history to optimize nutrient intake and therapeutic outcomes. Unlike generic solutions, it emphasizes data-driven customization to address specific deficiencies, goals, or conditions. The methodology supports proactive health management, enhances efficacy, and aligns with personalized medicine trends in nutrition, preventive care, and performance optimization.
Growth in direct-to-consumer health platforms
The rise of digital-first health platforms is transforming how consumer's access personalized supplementation. These platforms offer tailored nutrient plans based on genetic, lifestyle, and biometric data, eliminating the need for traditional clinical visits. Enhanced user interfaces and AI-driven recommendation engines are making personalized nutrition more accessible and scalable. As consumers increasingly seek autonomy over their health decisions, direct-to-consumer models are gaining traction.
Lack of standardized guidelines for personalized formulations
Variability in ingredient sourcing, dosage customization and testing protocols can lead to inconsistent product efficacy. Regulatory ambiguity across regions further complicates market entry for new players. Without harmonized frameworks, manufacturers struggle to validate claims and ensure safety across diverse consumer profiles. This lack of standardization may hinder consumer trust and slow adoption rates in certain demographics.
Collaborations with biotech and nutrigenomics firms
Strategic partnerships with biotech and nutrigenomics companies are unlocking new frontiers in hyper personalization. These collaborations enable the integration of genomic sequencing, microbiome analysis, and metabolic profiling into supplement design. By leveraging advanced biological data, firms can create precision formulations that align with individual health markers. Such alliances also facilitate clinical validation and regulatory compliance, enhancing credibility.
Competitive pressure from generic supplement brands
Generic supplement manufacturers continue to dominate shelf space due to their affordability and widespread availability. Their mass-market appeal and established distribution networks pose a threat to niche personalized offerings. Consumers with limited awareness or budget constraints may opt for conventional products over customized alternatives. Additionally, aggressive pricing strategies and promotional campaigns by generic brands can dilute the perceived value of hyper personalized solutions.
The pandemic catalyzes interest in immune health and personalized wellness, driving short-term growth in hyper personalized supplementation. However, supply chain disruptions and reduced clinical testing capacity temporarily slowed product development. On the consumer side, heightened health consciousness and remote diagnostics boosted demand for tailored solutions. The shift toward telehealth and digital nutrition platforms created new distribution channels and engagement models.
The botanical & herbal extracts segment is expected to be the largest during the forecast period
The botanical & herbal extracts segment is expected to account for the largest market share during the forecast period propelled by, their natural origin and broad therapeutic applications. These ingredients are favored for their adaptogenic, anti-inflammatory, and antioxidant properties, which align with personalized health goals. Advances in extraction technologies and traceability systems have improved product quality and consumer confidence. Additionally, cultural familiarity and growing preference for plant-based solutions are driving demand across age groups.
The microbiome-based personalization segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the microbiome-based personalization segment is predicted to witness the highest growth rate, influenced by, breakthroughs in gut health research and sequencing technologies. Supplements tailored to individual microbiome profiles offer targeted benefits for digestion, immunity, and mental well-being. The integration of stool testing kits and AI-driven microbiome analytics is making personalization more precise and scalable. As scientific understanding of the gut-brain axis deepens, consumer interest in microbiome modulation is surging.
During the forecast period, the North America region is expected to hold the largest market share, fuelled by, robust digital health ecosystem and high consumer awareness. The region's advanced healthcare infrastructure and widespread adoption of wearable devices enable seamless data collection for personalized formulations. Regulatory support for nutraceutical innovation and strong e-commerce penetration further bolster market growth. Leading companies in the U.S. and Canada are investing in AI, genomics, and direct-to-consumer models, reinforcing regional dominance.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by, rising disposable incomes, urbanization, and growing interest in personalized wellness. Countries like China, India, and South Korea are witnessing rapid adoption of digital health tools and genetic testing services. Government initiatives promoting preventive healthcare and local manufacturing are creating fertile ground for market expansion. Cultural emphasis on herbal medicine and dietary balance complements the personalized supplementation narrative.
Key players in the market
Some of the key players in Hyper Personalized Supplementation Market include Baze Labs, Persona Nutrition, Rootine, Nutrigenomix, Viome, DNAfit, Habit (Viome-acquired), Tespo, Elo Health, Sun Genomics, Vitagene, MyDNA, InsideTracker, Thorne HealthTech, and Biohm Health.
In November 2025, Habit announced its entry into Dodger Stadium with a new restaurant concept launching in Spring 2026. The move boosts brand visibility and consumer engagement. Though unrelated to Viome's nutrition platform, it reflects Habit's broader lifestyle positioning.
In July 2025, Viome and Scripps launched a 1,000-patient study for an at-home RNA test to detect colon polyps. The test aims to outperform DNA-based kits in early cancer detection. It marks a milestone in RNA-based preventive diagnostics.
In June 2025, Baze Labs, known for personalized vitamin packs, was acquired and integrated into Nature's Way's portfolio. The move strengthens its biochemical testing-based supplement model. The acquisition supports broader distribution and R&D scaling.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.